Bausch Health Companies (TSE:BHC) Upgraded to “Hold” by Evercore ISI

Bausch Health Companies (TSE:BHC) was upgraded by investment analysts at Evercore ISI to a “hold” rating in a report released on Tuesday, Zacks.com reports.

Separately, Raymond James raised Bausch Health Companies to a “hold” rating in a report on Wednesday, July 10th.

Bausch Health Companies Stock Performance

Bausch Health Companies stock opened at C$11.66 on Tuesday. The firm has a market capitalization of C$4.28 billion, a PE ratio of -6.66, a price-to-earnings-growth ratio of 0.21 and a beta of 0.77. Bausch Health Companies has a one year low of C$5.45 and a one year high of C$15.43. The stock’s 50 day moving average price is C$9.17 and its 200 day moving average price is C$10.00. The company has a debt-to-equity ratio of 7,583.76, a quick ratio of 0.58 and a current ratio of 1.19.

Bausch Health Companies (TSE:BHC) last posted its earnings results on Thursday, August 1st. The company reported C$1.22 EPS for the quarter, hitting analysts’ consensus estimates of C$1.22. Bausch Health Companies had a negative net margin of 5.12% and a negative return on equity of 2,304.54%. The business had revenue of C$3.29 billion for the quarter, compared to analysts’ expectations of C$3.20 billion. As a group, sell-side analysts expect that Bausch Health Companies will post 5.5472637 EPS for the current fiscal year.

Insider Activity at Bausch Health Companies

In related news, Senior Officer Seana Lynne Carson sold 13,370 shares of Bausch Health Companies stock in a transaction dated Friday, September 6th. The shares were sold at an average price of C$8.38, for a total value of C$112,087.40. Insiders own 11.28% of the company’s stock.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.